IMFINZI (Durvalumab) 500 mg Injection
IMFINZI Durvalumab 500 mg Injection is an advanced immunotherapy medicine used in modern cancer treatment. It contains Durvalumab, a programmed death-ligand 1 (PD-L1) blocking antibody that helps activate the immune system to recognize and destroy cancer cells. It is commonly used in cancers such as non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and certain biliary tract cancers, often as maintenance therapy after chemotherapy or radiotherapy.
This medicine is part of immune checkpoint inhibitor therapy, designed to enhance the body’s natural ability to fight cancer by preventing tumor cells from escaping immune detection.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Durvalumab
- Strength: 500 mg per vial
- Dosage Form: Intravenous (IV) infusion
- Drug Class: Immune checkpoint inhibitor (PD-L1 monoclonal antibody)
How It Works
IMFINZI works by:
- Blocking PD-L1 proteins on cancer cells
- Restoring immune T-cell activity
- Helping the immune system detect and destroy tumors
- Slowing cancer progression and recurrence
Uses and Treatments
IMFINZI (Durvalumab) Injection is used for:
- Non-Small Cell Lung Cancer (NSCLC)
- Extensive Stage Small Cell Lung Cancer (SCLC)
- Biliary Tract Cancer
- Bladder and urothelial cancers (selected cases)
- Maintenance therapy after chemoradiation in lung cancer
Dosage and How to Use
- Administered as intravenous infusion only in hospitals/clinics
- Given every 2–4 weeks depending on treatment protocol
- Dose is determined by an oncologist based on body weight and condition
- Must be administered under strict medical supervision
Advantages of IMFINZI (Durvalumab)
- Strengthens immune system against cancer cells
- Improves survival in certain advanced cancers
- Used as maintenance therapy after chemotherapy/radiotherapy
- Targeted immunotherapy approach with precise action
- Helps delay cancer progression and recurrence
Storage Conditions
- Store at 2°C to 8°C (refrigerated)
- Do not freeze
- Keep in original carton to protect from light
- Do not shake vial
- For hospital/oncology use only
Alternative Indian Brands / Options
Durvalumab is a patented immunotherapy, so no direct Indian generic version is available. However, similar immune checkpoint inhibitors used in oncology include:
- Keytruda (Pembrolizumab) by Merck & Co.
- Opdivo (Nivolumab) by Bristol Myers Squibb
- Tecentriq (Atezolizumab) by Roche
- Oncology biosimilars and cancer therapies from Dr. Reddy’s Laboratories
All treatment alternatives must be prescribed by an oncologist.
Buy IMFINZI Durvalumab 500 mg Injection Online in the United States – Trusted Oncology Medicine Exporter
Looking to buy IMFINZI Durvalumab 500 mg Injection in the United States of America? GlobMedIndia is a trusted international medicine exporter of oncology and immunotherapy drugs, offering safe, genuine, and high-quality cancer medicines with secure global delivery across United States.
We supply advanced immunotherapy medicines used in modern cancer treatment protocols with strict pharmaceutical handling and export standards.
Coverage includes major US cities such as:
California, Washington, Chicago, Los Angeles, Houston, Phoenix, Austin, Columbus, Philadelphia, San Antonio, San Diego, Dallas, and Jacksonville.
Why Choose GlobMedIndia?
- Trusted exporter of oncology medicines
- Fast and secure international delivery
- 100% genuine pharmaceutical products
- Reliable global healthcare supply network
- Expert support for hospital procurement
- Buy Durvalumab 500 mg USA
- IMFINZI injection price USA
- Lung cancer immunotherapy USA
- PD-L1 inhibitor medicine USA
- Cancer immunotherapy injection USA
- Oncology medicine exporter USA
- GlobMedIndia cancer drugs
👉 Order Now for Fast, Safe & Secure Delivery Across the United States!
